Product Information
XELSTRYM 9 MG/9 HR PATCH is a brand product labeled by Noven Therapeutics, LLC, priced at $16.2602 per EA under NDC 68968021003. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Mar 22, 2022.
Strength
9 mg/1
Manufacturer
Noven Therapeutics, LLCNDC
68968021003
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
DEXTROAMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA215401FDA Approved
3/22/2022
On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for XELSTRYM 9 MG/9 HR PATCH has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 4.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.2602 per EA |
|---|---|
| All-time high | $16.3468 (Jun 11, 2025) |
| All-time low | $15.5687 (Nov 20, 2024) |
| 52-week high | $16.3133 |
| 52-week low | $16.2602 |
| Median price | $16.2712 |
| Average price | $16.1547 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTROAMPHETAMINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Noven Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXTROAMPHETAMINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XELSTRYM 9 MG/9 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for XELSTRYM 9 MG/9 HR PATCH, manufactured by Noven Therapeutics, LLC, is $16.2602 per EA (NDC 68968021003), effective Sep 30, 2026.
How has the price of XELSTRYM 9 MG/9 HR PATCH changed over time?
Over the history we have for it, the NADAC for XELSTRYM 9 MG/9 HR PATCH has risen 4.0%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for XELSTRYM 9 MG/9 HR PATCH?
Since Jul 17, 2024, the NADAC for XELSTRYM 9 MG/9 HR PATCH has ranged from a low of $15.5687 (Nov 20, 2024) to a high of $16.3468 (Jun 11, 2025), with a median of $16.2712 per EA.
Are there cheaper alternatives to XELSTRYM 9 MG/9 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of XELSTRYM 9 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XELSTRYM 9 MG/9 HR PATCH?
XELSTRYM 9 MG/9 HR PATCH (NDC 68968021003) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a brand product.